ClinConnect ClinConnect Logo
Search / Trial NCT07056504

Technologies and Systems for Assessing Human Energy Metabolism and Nutritional Rehabilitation

Launched by SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY ,CHINESE ACADEMY OF SCIENCES · Jun 29, 2025

Trial Information

Current as of July 23, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how the body’s energy use changes during recovery for people who have had a stroke, traumatic brain injury, or major surgery. Researchers want to better understand energy needs during rehabilitation by collecting detailed information like body measurements, activity levels, eating habits, sleep quality, brain function, and movement. They will also analyze blood and stool samples to learn more about metabolism. This information will help create computer-based models to predict energy requirements specific to different types of injuries.

People who may be eligible are adults between 20 and 70 years old who are currently in rehabilitation after a stroke or movement-related injury. To take part, individuals need to be able to move on their own and lie flat for about an hour, and they cannot have certain health conditions like severe metabolic diseases, metal implants, or be pregnant. Participants can expect a thorough set of tests including physical measurements, activity tracking, cognitive tests, and sample collections. This study is not yet recruiting, but it aims to improve how we support people’s nutrition and energy needs during recovery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male and female participants aged 20 to 70 years old;
  • Rehabilitation patients with stroke or motor injuries;
  • Exclusion Criteria:
  • Loss of autonomous mobility;
  • Loss of consciousness;
  • Individuals with metallic implants (e.g., pacemakers);
  • Severe metabolic diseases (e.g., diabetes, other hereditary metabolic disorders);
  • Patients with claustrophobia;
  • Individuals with anorexia nervosa;
  • Women in the preconception period, pregnancy, or lactation;
  • Uremic patients;
  • Inability to lie flat for one hour.

About Shenzhen Institutes Of Advanced Technology ,Chinese Academy Of Sciences

The Shenzhen Institutes of Advanced Technology (SIAT), part of the Chinese Academy of Sciences, is a leading research institution dedicated to advancing scientific knowledge and technology across various fields, including biomedical research. SIAT is committed to fostering innovation through interdisciplinary collaboration and state-of-the-art facilities, focusing on the translation of research into practical applications. With a strong emphasis on clinical trials and regulatory compliance, SIAT aims to contribute to the global healthcare landscape by developing novel therapies and solutions that address pressing medical challenges.

Locations

Patients applied

0 patients applied

Trial Officials

Xueying Zhang, PhD

Principal Investigator

Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported